Valuation Grace Therapeutics, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-28 EDT			5-day change	1st Jan Change
2.250 ^USD	-2.17%		-7.41%	-34.97%

07-28	Grace Therapeutics Receives Type a Meeting Minutes from FDA and Provides Update on GTx-104 Clinical-Stage Injectable Formulation	CI
06-29	Grace Therapeutics, Inc.(NasdaqCM:GRCE) added to Russell Microcap Value Benchmark Index	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	67.46	27.76	43.57	44.96	100	51.59	-	-
Change	-	-58.85%	56.94%	3.19%	122.45%	-48.41%	-	-
Enterprise Value (EV)	67.46	27.76	43.57	44.96	100	51.59	51.59	51.59
Change	-	-58.85%	56.94%	3.19%	122.45%	-48.41%	0%	0%
P/E	-4.36x	-0.5x	-2.5x	-3.02x	-9.8x	-4.3x	-4.09x	6.62x
PBR	-	-	-	-	-	-	-	-
PEG	-	-0x	0x	0.1x	0.2x	-0.4x	-0.8x	-0x
Capitalization / Revenue	-	-	-	-	-	-	6.59x	0.84x
EV / Revenue	-	-	-	-	-	-	6.59x	0.84x
EV / EBITDA	-	-	-	-0x	-0x	-4.44x	-2.98x	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-4.04x	-2.52x	2.67x
EV / FCF	-	-	-0x	-0x	-0x	-4.44x	-0.57x	-3.77x
FCF Yield	-	-	-38.9%	-45.6%	-12.5%	-22.5%	-177%	-26.5%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-2.094	-7.529	-1.851	-1.085	-0.6593	-0.737	-0.7745	0.479
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	-	-	-	-	7.834	61.57
EBITDA ¹	-	-	-	-22.9	-15.65	-11.62	-17.3	-
EBIT ¹	-20.25	-24.56	-15.59	-22.91	-15.54	-12.76	-20.46	19.29
Net income ¹	-12.76	-55.88	-17.63	-13.14	-10.93	-12.76	-20.46	19.29
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	9.139	3.733	4.635	3.277	6.463	3.170	3.170	3.170
Nbr of stocks (in thousands)	7,381	7,435	9,399	13,718	15,474	16,274	-	-
Announcement Date	6/21/22	6/23/23	6/21/24	6/23/25	6/18/26	-	-	-

¹CAD in Million²CAD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GRACE THERAPEUTICS, INC.	-4.3x	-	-	-	36.29M
ARGENX SE	32.44x	8.02x	24.72x	0.05%	55.01B
WUXI APPTEC CO., LTD.	20.35x	6.27x	13.72x	1.56%	54.24B
BIONTECH SE	-18.46x	4.46x	-7.81x	-.--%	23.38B
INSMED INCORPORATED	-40.77x	12.94x	-38.12x	-.--%	22.57B
WUXI BIOLOGICS (CAYMAN) INC.	25.4x	4.97x	13.15x	-.--%	20.19B
GENMAB A/S	24.92x	4.83x	15.71x	-.--%	17.86B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-778.79x	36.99x	-4163.86x	-.--%	15.5B
PHARMAESSENTIA CORPORATION	42.81x	17.28x	44.49x	0.09%	14.2B
EXELIXIS, INC.	17.78x	5.16x	12.03x	-.--%	14.2B
Average	-67.86x	11.21x	-454.00x	0.19%	23.72B
Weighted average by Cap.	-36.75x	9.51x	-261.99x	0.37%